Faculty Information - Katsuhiko Shimizu

Present specialized field

Journal

Presentation

Belonging society

（Last updated : 2024-09-12 08:45:21）

Katsuhiko Shimizu
Department Kawasaki Medical School Kawasaki Medical School, Department of General Thoracic Surgery,

Position Associate Professor

■ Present specialized field

Respiratory surgery, General surgery and pediatric surgery

■ Journal

1.	2019/11/26	Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
2.	2019/08	Effects of serratus plane block and epidural analgesia on stress hormones after thoracoscopic lung surgery: a randomized trial.
3.	2019/12/01	Serum Antibody against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC.
4.	2019/08	Effect of platinum-based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death-1 ligand 1 and HLA class I in non-small cell lung cancer
5.	2019/05	Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
6.	2018/10	Deciduoid type malignant pleural mesothelioma: a case report
7.	2018/09	Epithelial-mesenchymal transition-induced metastasis could be a bait for natural killer cells
8.	2018/08	Impact of COX2 Inhibitor for Regulation of PD-L1 Expressioin in Non-small Cell Lung Cancer
9.	2017/10	Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma.
10.	2017/08	Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer.
11.	2016/12	Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
12.	2015/09	Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
13.	2015/09	Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small cell lung cancer
14.	2015/08	Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
15.	2015/01	Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer.
16.	2015/02	Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
17.	2014/11	Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
18.	2014/05	Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma.
19.	2013/12	Lung cancer with sarcoid reaction in the lymph nodes following chemoradiotherapy
20.	2013/07	Clinical significance of the tumor microenvironment in non-small cell lung cancer
21.	2013/11	Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer
22.	2012/09	Characteristics of Non-Small Cell Lung Cancer Located in the Right Middle Lobe According to a Retrospective Study of Recurrence and Prognosis
23.	2012/07	Membrane-bound Estrogen Receptor-alpha Expression and Epidermal Growth Factor Receptor Mutation are Associated with a Poor Prognosis in Lung Adenocarcinoma Patients
24.	2012/02	Maximal Standardized Uptake Value on FDG-PET Is Correlated With Cyclooxygenase-2 Expression in Patients With Lung Adenocarcinoma
25.	2011/10	Interstitial lung disease after re-administration of gefitinib in a responder with no adverse effects during the first administration: a case report
26.	2010/10	Induction Chemoradiation Therapy with Cisplatin plus Irinotecan Followed by Surgical Resection for Superior Sulcus Tumor
27.	2010/11	A case of simultaneous lung cancer and abdominal aortic aneurysm treated with a two-stage strategy
28.	2010/05	Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
29.	2008/12	Long Survial after Resection for Lung Metastasis of Malignant Peripheral Nerve Sheath Tumor in Neurofibromatosis 1
30.	2008/06	Recent results regarding the clinical impact of smoking history on postoperative complications in lung cancer patients
31.	2008/07	Teratoma with malignant transformation in the anterior mediastinum.
32.	2006/02	Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2cm and revealed by ground-glass opacity at CT
33.	2005/09	Clinical Evaluation of Low-dose Cisplatin and 5-Fluorouracil as Adjuvant Chemoradiotherapy for Advanced Squamous Cell Carcinoma of the Esophagus
34.	2024/07/30	Predictive Value of PERCIST for Locally Advanced Non-Small Cell Lung Cancer Treated with Preoperative Induction Therapy – A Multicenter Study in Japan
35.	2023/11/10	A case of an atypical variant of type A thymoma presenting with a gradually enlarging tumor over a 10-year period
36.	2023/11/01	INFORMED CONSENT IN SURGERY FOR PRIMARY LUNG CANCER
37.	2023/01/11	Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
38.	2021/11	Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
39.	2021/08/06	The biological Characteristics of Solid Components are Different between Part-Solid-Type and Solid-Type in Lung Adenocarcinoma
40.	2021/05/24	Pulmonary Resection of the Primary Tumor for Patients with Stage IV Non-Small-Cell Lung Cancer
41.	2021/01/24	Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
42.	2020/09/01	Perioperative Therapy for Non-Small Cell Lung Cancer - Current Status and Future Perspective -
43.	2017/07	PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
44.	2016/06	Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report.
45.	2016/03	MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small-cell lung cancer
46.	2015/12	Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells.
47.	2015/10	Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
48.	2014/04	A case report of intrapulmonary schwannoma.
49.	2014	Clinical significance of vascular endothelial growth factor and Delta-like ligand 4 in small pulmonary adenocarcinoma
50.	2013/11	Case of pleural metastasis of prostate cancer.
51.	2013/09	Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum.
52.	2013/07	Role of 2-[18F]Fluoro-2-deoxyglucose positron emission tomography in Preoperative Management of Solid-Type Small-Sized Lung Cancer
53.	2013/02	Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy
54.	2013/01	Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis
55.	2013	CT, MRI, and 18F-FDG PET-CT findings of pulmonary benign metastasizing leiomyoma: A case report
56.	2012/12	Current status of Radiologic Diagnosis for Mediastinal Lymph Node Metastases of Non-Small-Cell Lung Cancer: Retrospective Study of pN2 Cases
57.	2012/12	Successful Two-Stage Surgical Treatment for Lung Cancer in a Patient with Contralateral Giant Emphysematous Bullae
58.	2010/08	Suggestive synchronous triple squamous cell carcinoma of the lung in the same lobe
59.	2010/04	Pulmonary Apical Mass,the So-Called Pulmonary Apical Cap,in a 43-Year-Old Woman
60.	2008	Pappillary Fibroelastoma Developing from the Left Ventricular Septum
61.	2007/05	Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma.
62.	2007	Pure red cell aplasia and myasthenia gravis with recurrent thymoma.
63.	2003/11	Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: Induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes.
Display 5 items
Display all(63)

■ Presentation

1.	2018/07/19	PD-L1 expression correlates with Cox-2 expression but is not down-regulated by Cox-2 inhibitor in lung cancer （Speech，General）
2.	2017/10/17	Prognostic Value of Cox-2 Expression Differs Depending on Tummor CD8+ T Lymphocytes and PD-L1 Expression in Resected Lung Adenocarcinoma. （Poster notice，General）
3.	2009/11/01	Tumor-Infiltrating Foxp3+ Regulaory T Cells Are Correlated with Cyclooxygenese-2 Expression and are associated with Recurrence in Resected Non-Small Cell Lung Cance （Poster notice，General）
4.	2009/08/03	Tumor Infiltrating Foxp3+ Regulatory T Cells Are Correlated with Cyclooxygenese-2 Expression and Associated with Recurrence in Resected NSCLC （Poster notice，General）
5.	2023/10/20	Feasibility of Sublobar Resection for Small-Sized Peripheral Stage IA Squamous Cell Carcinoma （Speech，General）
6.	2023/09/20	Antibodies against tumor-associated antigens are associated with response to immune checkpoint therapy for non-small-cell lung cancer （Poster notice，General）
7.	2023/04/27	Informed Consent in Surgery for Primary Lung Cancer （Speech，Panelist at Symposium/Workshop (Applied)）
Display 5 items
Display all(7)

■ Belonging society

2005/10～

IASLC